Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 4, 2005, Pages 355-361

  Oda, Shigeto ^a   Hirasawa, Hiroyuki ^a   Shiga, Hidetoshi ^a   Matsuda, Kenichi ^a   Nakamura, Masataka ^a   Watanabe, Eizo ^a   Moriguchi, Takeshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Abdominal compartment syndrome; Continuous hemodiafiltration; Cytokine; Interleukin 6; Intra abdominal hypertension; Severe acute pancreatitis

Indexed keywords

INTERLEUKIN 6; POLY(METHYL METHACRYLATE);

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL DISEASE; ABDOMINAL PRESSURE; ACUTE PANCREATITIS; ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIAFILTRATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALE; MEMBRANE FILTER; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 29144431644     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2005.00297.x     Document Type: Article

References (33)

1. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004;291:2865-8.
2. Raraty MG, Connor S, Criddle DN, Sutton R, Neoptolemos JP. Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 2004;6:99-103.
3. Gross V, Leser H-G, Heinisch A, Scholmerich J. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenteroloy 1993;40:522-30.
4. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
5. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Crit Care Med 1999;27:749-55.
6. Nathens AB. Mediator-directed therapy in pancreatitis and trauma. Sepsis 1999;3:57-64.
7. Makhija R, Kingnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9:401-10.
8. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfield GL. Abdominal compartment syndrome. J Trauma 1998;45:597-609.
9. Sieh K-M, Chu K-M. Wong J. Intraabdominal hypertension and abdominal compartment syndrome. Langenbecks Arch Surg 2001;386:53-61.
10. McNelis J, Soffer S, Marini CP et al. Abdominal compartment syndrome in the surgical intensive care unit. Am Surg 2002;68:18-23.
11. Hirasawa H, Oda S, Shiga H, Matsuda K. Endotoxin adsorption or hemodiafiltration in the treatment of multiple organ failure. Curr Opin Crit Care 2000;6:421-5.
12. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies. Ther Apher 2001;5:306-14.
13. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Continuous hemofiltration/ hemodiafiltration in critical care. Ther Apher 2002;6:193-8.
14. Moriguchi T, Hirasawa H, Oda S et al. A patient with severe acute pancreatitis successfully treated with a new critical care procedure. Ther Apher 2002;6:221-4.
15. Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633-8.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
17. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-6.
18. Yokoi H, Naganuma T, Higashiguchi T, Isaji S, Kawarada Y. Prognostic study of a protocol for selection of treatment of acute pancreatitis based on scoring of severity. Digestion 1999;60:14-18.
19. Ohtake Y, Hirasawa H, Sugai T et al. Nafamostat mesilate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 1991;93:215-17.
20. Amato MB, Barbas CS, Medeiros DM et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347-54.
21. Schultz MJ, de Jonge E, Kesecioglu J. Selective decontamination of the digestive tract reduces mortality in critically ill patients. Crit Care 2003;7:107-10.
22. Cheatham ML, Safcsak K. Intraabdominal pressure: a revised method for measurement. J Am Coll Surg 1998;186:594-5.
23. Kron IL, Harman PK, Nolan SP. The measurement of intraabdominal pressure as a criterion for abdominal re-exploration. Ann Surg 1984;199:28-30.
24. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
25. Berney T, Gasche Y, Robert J et al. Serum profiles of interleukin-6, interleukin-8 and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999;18:371-7.
26. O'Reilly M, Newcomb DE, Remick D. Endotoxin, sepsis, and the primrose path. Shock 1999;12:411-20.
27. Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 2000;47:1147-50.
28. Takeda K, Matsuno S, Sunamura M, Kakugawa Y. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg 1996;171:394-8.
29. Hirasawa H, Oda S, Shiga H, Matsuda K, Abe R. Indication and clinical effect of continuous hemodiafiltration (CHDF) for severe acute pancreatits. Nippon Rinsho 2004;62:2094-100.
30. Gecelter G, Fahoum B, Gardezi S, Schein M. Abdominal compartment syndrome in severe acute pancreatitis: an indication for a decompressing laparotomy? Dig Surg 2002;19:402-5.
31. Tao J, Wang C, Chen L et al. Diagnosis and management of severe acute pancreatitis complicated with abdominal compartment syndrome. J Huazhong Univ Sci Technolog Med Sci 2003;23:399-402.
32. Buchler P, Reber HA. Surgical approach in patients with acute pancreatitis. Is infected or sterile necrosis an indication - in whom should this be done, when, and why? Gastroenterol Clin North Am 1999;28:661-71.
33. Werner J, Uhl W, Hartwig W et al. Modern phase-specific management of acute pancreatitis. Dig Dis 2003;21:38-45.